Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
- Resource Type
- Article
- Authors
- Amorim, Sandy; Stathis, Anastasios; Gleeson, Mary; Iyengar, Sunil; Magarotto, Valeria; Leleu, Xavier; Morschhauser, Franck; Karlin, Lionel; Broussais, Florence; Rezai, Keyvan; Herait, Patrice; Kahatt, Carmen; Lokiec, François; Salles, Gilles; Facon, Thierry; Palumbo, Antonio; Cunningham, David; Zucca, Emanuele; Thieblemont, Catherine
- Source
- In The Lancet Haematology April 2016 3(4):e196-e204
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2352-3026